HIGH-CONTENT ANALYSIS & PHENOTYPIC SCREENING 2016
- 高容量分析與表型篩選年會 2016年 -
2016年2月11 - 12日
美國,加州,聖地亞哥,Hilton San Diego Resort & Spa

  • The Longest Running HCA Meeting
High-Content Analysis Link   Phenotypic Screening Link


關於本年會

由CHI第13次主辦High-Content Analysis,不但是介紹高容量分析(HCA)應用與技術最新趨勢的重要會議,今年更加入了全新議程,跟去年一樣在美國加州聖地牙哥盛大舉行。近年來HCA技術日趨成熟,也逐漸被導入到化合物篩選、評估、功能分析等各種領域之中。HCA年會將著重於下一階段的科技發展,包括3D及具生理意義複合物模型的篩選、超高解析度及高通量影像、其他先進影像分析及數據管理、以及各種新試驗與應用。共同舉辦的第2屆Phenotypic Screening將聚焦於表型篩選與標的篩選的優劣、試驗開發、具生理意義模型的選擇與接隨而來的標的辨識、以及龍頭藥廠的表型篩選個案研究。與會者可參與High-Content Analysis及Phenotypic Screening的所有會議,聽取最先進的研究成果發表,在展示會大廳接觸最新技術,並參加用戶團體會議與晚餐會等活動。

主題

  • 利用表型篩選的藥物開發個案研究
  • 3D細胞培養的高容量分析與表型篩選
  • 包含類器官、器官型初代細胞、iPS細胞、球狀在內的最新篩選模型
  • 試驗開發與HCA領域的個案研究
  • 標的與途徑的識別與驗證
  • 表型篩選與高容量篩選的數據分析
  • 化學基因體學與化學蛋白質體學
  • 定量系統藥理學
  • 活細胞影像技術
  • 超高解析度影像技術

知名講者

Paul Andrews, Ph.D.
Director, National Phenotypic Screening Centre, University of Dundee, UK

Ulrich Broeckel, M.D.
Professor, Pediatrics, Medical College of Wisconsin

Anthony M. Davies, Ph.D.
Center Director, Translational Cell Imaging Queensland (TCIQ), Institute of Health Biomedical Innovation, Queensland University of Technology

Lauren Drowley, Ph.D.
Associate Principal Scientist, AstraZeneca

Su Guo, Ph.D.
Professor, Bioengineering and Therapeutic Sciences, University of California, San Francisco

Erik Hett, Ph.D.
Senior Scientist, Chemical & Molecular Therapeutics, Biogen

Susanne Heynen-Genel, Ph.D.
Director, High-Content Screening Systems, Sanford Burnham Prebys Medical Discovery Institute

Beatrice Knudsen, M.D., Ph.D.
Director, Translational Pathology, Cedars Sinai Medical Center

Ming Lei
Senior Scientist, Lead Discovery & Optimization, Bristol-Myers Squibb

Zhuyin Li, Ph.D.
Translational Biomarker Team Lead, Lead Discovery & Optimization, Bristol-Myers Squibb

David J. Logan, Ph.D.
Computational Biologist, Imaging Platform, Broad Institute of Harvard and MIT

Mary-Ann Mycek, Ph.D.
Professor and Associate Chair for Translational Research, Department of Biomedical Engineering, College of Engineering & Medical School, University of Michigan

Madhu Lal-Nag, Ph.D.
Acting Team Lead, RNAi Screening Facility, National Center for Advancing Translational Sciences, National Institutes of Health

Nathan Ross, Ph.D.
Senior Investigator, High Throughput Biology Group Leader, Novartis Institutes for BioMedical Research

Ulrich Schopfer, Ph.D.
Executive Director and Head, Integrated Lead Discovery, Novartis Institutes for BioMedical Research

Mark Schurdak, Ph.D.
Research Associate Professor, Computational and Systems Biology, University of Pittsburgh; Director, Drug Discovery Institute

D. Lansing Taylor, Ph.D.
Director, University of Pittsburgh Drug Discovery Institute and Allegheny Foundation Professor, Computational and Systems Biology, University of Pittsburgh

Andreas Vogt, Ph.D.
Associate Professor, Computational and Systems Biology, University of Pittsburgh

Alan Waggoner, Ph.D.
Professor, Biological Sciences, and Director, Molecular Biosensor and Imaging Center, Carnegie Mellon University

Wei Zheng, Ph.D.
Group Leader, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health

晚餐會

2月10日 (水) 、18:00∼21:00

高容量表型篩選入門

Instructor: Anthony M. Davies, Ph.D., Center Director, Translational Cell Imaging Queensland (TCIQ), Institute of Health Biomedical Innovation, Queensland University of Technology

2月11日 (木) 、18:00∼21:00

專家智庫:如何滿足具生理意義試驗的需求?

Moderator: Lisa Minor, Ph.D., President, In Vitro Strategies, LLC

Choose your language
Chinese
Japanese
Korean
English

Catalog


產業會議彙總曆
醫療設備相關國際會議

醫療設備相關國際會議

免費電子郵件通知服務
免費電子郵件通知服務